Rating
Buy
Price target
$320
Previous
$320
Implied upside
+13%

BofA Securities analyst Vivek Arya reiterated a Buy rating and $320.00 price target on Texas Instruments (NASDAQ: TXN).

“We hosted Mike Beckman, TXN’s head of IR, for a well-attended virtual fireside chat following strong Q1 results and above seasonal Q2 guide.

Recovery appears broader and better quality than last year’s 1H move.

TXN currently sees no evidence of pull-in from their customers as they remain cautiously optimistic on the durablity of demand into 2H.

TXN sees broad based strong industrial growth (+30% YoY, +20% QoQ in Q1) with every sub sector growing both sequentially and year-over-year.

Industrial remains 15% below the 2022 peak despite the strong quarter, supporting how the current rebound remains a catch-up to trend rather than an overshoot.

TXN was careful not to extrapolate too far; as in prior cycles, TXN’s direct model and short lead times mean only a limited portion of the Q is locked in, so mgmt. wants to let Q2 play out before making a stronger call on whether this upturn is durable or risks becoming another false start.

We maintain Buy and continue to like TXN’s high quality US-based profile within this recovery environment.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.